Page last updated: 2024-08-22

camptothecin and Kidney Neoplasms

camptothecin has been researched along with Kidney Neoplasms in 25 studies

Research

Studies (25)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (16.00)18.2507
2000's11 (44.00)29.6817
2010's10 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Azuma, H; Hirano, H; Ibuki, N; Inamoto, T; Matsunaga, T; Nomi, H; Saito, K; Takahara, K; Takai, T; Tanda, N; Tsujino, T; Uchimoto, T; Yoshikawa, Y1
Cohn, A; Crowell, T; Figlin, R; Haas, NB; Harris, WB; Hussain, A; Hutson, T; Keam, B; Lee, JL; Li, J; Motzer, RJ; Randall, JM; Rha, SY; Richey, S; Senderowicz, A; Shaffer, D; Stone, E; Vaishampayan, U; Vogelzang, N; Voss, MH1
Bergeron, C; Brok, J; Catania, S; Graf, N; Hol, JA; Howell, L; Kager, L; Mavinkurve-Groothuis, AMC; Pritchard-Jones, K; Spreafico, F; van den Heuvel-Eibrink, MM; van Tinteren, H; Verschuur, A1
Malogolowkin, MH; Mascarenhas, L; Venkatramani, R1
Ashcroft, M; Carroll, VA; Moumen, A; Nathawat, K; Selvarajah, J1
Cen, P; Rowe, J1
Deininger, E; Moch, H; Razafinjatovo, CF; Rechsteiner, M; Schraml, P; Stiehl, D1
Abe, K; Fujiwara, J; Hayashi, I; Ishida, H; Kawauchi, A; Miki, T; Mizuno, M; Mizutani, Y; Nakanishi, H; Okada, K; Toiyama, D; Yamamoto, K; Yoshida, J1
Burckhardt, G; Eckardt, R; Grottker, J; Gupta, S; Hagos, Y; Koepsell, H; Müller, GA; Shnitsar, V1
Heye, S; Maleux, G; Oyen, R; van Cutsem, E; Vaninbroukx, J1
Fujita, M; Koma, H; Nakamura, T; Okamura, N; Yagami, T; Yamamori, M; Yamamoto, Y1
Bertozzi, D; Capranico, G; Iurlaro, R; Marinello, J; Sordet, O; Zaffaroni, N1
Ansell, W; Nystrom, M; Oliver, RT; Shamash, J; Steele, JP; Wilson, P1
Chevreau, C; Culine, S; Droz, JP; Escudier, B; Fizazi, K; Mery-Mignard, D; Rolland, F1
Artru, P; De Gramont, A; Krulik, M; Louvet, C; Nahon, P; Tournigand, C1
Ansell, W; Oliver, T; Powles, T; Shamash, J; Wilson, P1
Crassard, N; Frappaz, D; Marec-Bérard, P; Philip, T; Ranchin, B; Schell, M; Thiesse, P1
Fujimoto, K; Hirao, Y; Matsushita, C; Miyake, M; Tanaka, M; Tanaka, N1
Bachelot, T; Biron, P; Blay, JY; Brantus, JF; Confavreux, C; Ghesquière, H; Guastalla, JP; Ray-Coquard, I; Rustam, F; Saba, C; Sebban, C1
Asano, T; Hayakawa, M; Horiguchi, A; Ito, K; Kakizoe, T; Koizumi, F; Matsumura, Y; Sumitomo, M1
Fields, SZ; Hargis, JB; Lilenbaum, RC; Miller, AA; Rosner, GL; Schilsky, RL1
Ilson, DH; Law, TM; Motzer, RJ1
Jimbo, T; Kumazawa, E; Ochi, Y; Tohgo, A1
Kojima, Y; Miki, T; Nishimura, K; Nonomura, N; Okuyama, A; Sawada, M; Takaha, N1
Bastow, KF; Cheng, HH; Ito, J; Lee, KH; Luo, TY; Nakanishi, Y; Tachibana, Y; Wang, HK; Xu, Z1

Reviews

2 review(s) available for camptothecin and Kidney Neoplasms

ArticleYear
TroVax in colorectal cancer.
    Human vaccines & immunotherapeutics, 2014, Volume: 10, Issue:11

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cancer Vaccines; Carcinoembryonic Antigen; Carcinoma, Renal Cell; Colonic Neoplasms; Fluorouracil; Humans; Immunotherapy; Kidney Neoplasms; Leucovorin; Membrane Glycoproteins; Organoplatinum Compounds; Vaccination; Vaccines, DNA; Vaccinia virus

2014
[Are antiangiogenic antibodies universal for solid tumor?].
    Bulletin du cancer, 2007, Volume: 94 Spec No

    Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Breast Neoplasms; Camptothecin; Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Fluorouracil; Humans; Hypertension; Kidney Neoplasms; Leucovorin; Lung Neoplasms; Neoplasms; Neovascularization, Pathologic; Receptors, Vascular Endothelial Growth Factor; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors

2007

Trials

6 trial(s) available for camptothecin and Kidney Neoplasms

ArticleYear
A randomized phase II trial of CRLX101 in combination with bevacizumab versus standard of care in patients with advanced renal cell carcinoma.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2017, Nov-01, Volume: 28, Issue:11

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Camptothecin; Carcinoma, Renal Cell; Cyclodextrins; Female; Follow-Up Studies; Humans; Kidney Neoplasms; Lymphatic Metastasis; Male; Prognosis; Standard of Care; Survival Rate

2017
Irinotecan for relapsed Wilms tumor in pediatric patients: SIOP experience and review of the literature-A report from the SIOP Renal Tumor Study Group.
    Pediatric blood & cancer, 2018, Volume: 65, Issue:2

    Topics: Adolescent; Camptothecin; Child; Child, Preschool; Female; Follow-Up Studies; Humans; Irinotecan; Kidney Neoplasms; Male; Risk Factors; Wilms Tumor

2018
IPM chemotherapy in cytokine refractory renal cell cancer.
    British journal of cancer, 2003, May-19, Volume: 88, Issue:10

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Renal Cell; Cisplatin; Disease Progression; Drug Resistance, Neoplasm; Female; Humans; Infusions, Intravenous; Injections, Intravenous; Irinotecan; Kidney Neoplasms; Male; Middle Aged; Mitomycin; Neoplasm Metastasis; Survival; Treatment Outcome

2003
A phase II study of irinotecan in patients with advanced renal cell carcinoma.
    Cancer, 2003, Jul-01, Volume: 98, Issue:1

    Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Camptothecin; Carcinoma, Renal Cell; Female; Humans; Irinotecan; Kidney Neoplasms; Male; Middle Aged; Survival Rate; Topoisomerase I Inhibitors; Treatment Outcome

2003
Phase I study of topotecan and cisplatin in patients with advanced solid tumors: a cancer and leukemia group B study.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1994, Volume: 12, Issue:12

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Camptothecin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Colorectal Neoplasms; Dose-Response Relationship, Drug; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Kidney Neoplasms; Lung Neoplasms; Male; Middle Aged; Neoplasms; Neoplasms, Unknown Primary; Neutropenia; Recombinant Proteins; Salivary Gland Neoplasms; Stomach Neoplasms; Topotecan

1994
Phase II trial of topotecan in patients with advanced renal cell carcinoma.
    Investigational new drugs, 1994, Volume: 12, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Bone Marrow Diseases; Camptothecin; Carcinoma, Renal Cell; Female; Humans; Kidney Neoplasms; Male; Middle Aged; Neoplasm Staging; Topotecan

1994

Other Studies

17 other study(ies) available for camptothecin and Kidney Neoplasms

ArticleYear
Remarkable response to fluorouracil, leucovorin, oxaliplatin, and irinotecan therapy in urothelial cancer of the renal pelvis: a case report.
    Journal of medical case reports, 2017, Apr-10, Volume: 11, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Renal Cell; Colostomy; Fluorouracil; Humans; Irinotecan; Kidney Neoplasms; Kidney Pelvis; Leucovorin; Male; Middle Aged; Neoadjuvant Therapy; Organoplatinum Compounds; Oxaliplatin; Remission Induction; Treatment Outcome; Ureterostomy; Urologic Neoplasms; Urothelium

2017
Treatment of multiply relapsed wilms tumor with vincristine, irinotecan, temozolomide and bevacizumab.
    Pediatric blood & cancer, 2014, Volume: 61, Issue:4

    Topics: Adolescent; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Camptothecin; Child; Dacarbazine; Female; Humans; Irinotecan; Kidney Neoplasms; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Temozolomide; Vincristine; Wilms Tumor

2014
Chemotherapy-mediated p53-dependent DNA damage response in clear cell renal cell carcinoma: role of the mTORC1/2 and hypoxia-inducible factor pathways.
    Cell death & disease, 2013, Oct-17, Volume: 4

    Topics: Apigenin; Apoptosis; Basic Helix-Loop-Helix Transcription Factors; Camptothecin; Carcinoma, Renal Cell; Cell Hypoxia; Cell Line, Tumor; DNA Damage; Endothelin-1; Gene Expression Regulation, Neoplastic; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Kidney Neoplasms; Mechanistic Target of Rapamycin Complex 1; Mechanistic Target of Rapamycin Complex 2; Multiprotein Complexes; Protein Biosynthesis; RNA, Messenger; Signal Transduction; TOR Serine-Threonine Kinases; Tumor Suppressor Protein p53

2013
VHL missense mutations in the p53 binding domain show different effects on p53 signaling and HIFα degradation in clear cell renal cell carcinoma.
    Oncotarget, 2017, Feb-07, Volume: 8, Issue:6

    Topics: Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Camptothecin; Carcinoma, Renal Cell; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyclin-Dependent Kinase Inhibitor p21; Elongin; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Indoles; Kidney Neoplasms; Mutation, Missense; Protein Binding; Protein Interaction Domains and Motifs; Proteolysis; Proto-Oncogene Proteins c-bcl-2; Pyrroles; Signal Transduction; Sunitinib; Transfection; Tumor Suppressor Protein p53; Von Hippel-Lindau Tumor Suppressor Protein

2017
Significant antitumor activity of cationic multilamellar liposomes containing human interferon-beta gene in combination with 5-fluorouracil against human renal cell carcinoma.
    International journal of oncology, 2008, Volume: 33, Issue:3

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Renal Cell; Cations; Cisplatin; Deoxycytidine; Doxorubicin; Female; Fluorouracil; Gemcitabine; Humans; Immunotherapy; Interferon-beta; Irinotecan; Kidney Neoplasms; Liposomes; Mice; Mice, SCID; Paclitaxel; Thymidine Phosphorylase; Thymidylate Synthase; Xenograft Model Antitumor Assays

2008
Expression of human organic cation transporter 3 in kidney carcinoma cell lines increases chemosensitivity to melphalan, irinotecan, and vincristine.
    Cancer research, 2009, Feb-15, Volume: 69, Issue:4

    Topics: Animals; Antineoplastic Agents; Camptothecin; Cell Division; Cell Line, Tumor; Cell Survival; CHO Cells; Cricetinae; Cricetulus; DNA Primers; Humans; Irinotecan; Kidney Neoplasms; Melphalan; Organic Cation Transport Proteins; Reverse Transcriptase Polymerase Chain Reaction; Transfection; Vincristine

2009
Aneurysm formation in an angiomyolipoma during bevacizumab combination therapy.
    Acta oncologica (Stockholm, Sweden), 2010, Volume: 49, Issue:6

    Topics: Aneurysm; Angiogenesis Inhibitors; Angiomyolipoma; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Camptothecin; Colorectal Neoplasms; Female; Fluorouracil; Humans; Kidney Neoplasms; Leucovorin; Liver Neoplasms; Middle Aged; Neoplasms, Second Primary; Tomography, X-Ray Computed

2010
15-Deoxy-Δ12,14-prostaglandin J2 enhanced the anti-tumor activity of camptothecin against renal cell carcinoma independently of topoisomerase-II and PPARγ pathways.
    Biochemical and biophysical research communications, 2011, Jul-08, Volume: 410, Issue:3

    Topics: Anilides; Antineoplastic Agents; Apoptosis; Camptothecin; Carcinoma, Renal Cell; Caspase 3; Cell Line, Tumor; DNA Topoisomerases, Type II; Drug Synergism; Enzyme Activation; Humans; Kidney Neoplasms; PPAR gamma; Prostaglandin D2

2011
Characterization of novel antisense HIF-1α transcripts in human cancers.
    Cell cycle (Georgetown, Tex.), 2011, Sep-15, Volume: 10, Issue:18

    Topics: Camptothecin; Cell Fractionation; Cloning, Molecular; Deferoxamine; Female; Fluorescent Antibody Technique; Gene Expression Regulation, Neoplastic; HCT116 Cells; HeLa Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; In Situ Hybridization, Fluorescence; Kidney Neoplasms; Male; Membrane Glycoproteins; Neoplasm Grading; Nuclear Envelope; Nuclear Pore Complex Proteins; RNA, Antisense; RNA, Untranslated; Transcriptional Activation

2011
[Renal metastasis after curative resection of an epidermoid carcinoma of the esophagus].
    Gastroenterologie clinique et biologique, 2003, Volume: 27, Issue:5

    Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Camptothecin; Carcinoma, Squamous Cell; Cisplatin; Deglutition Disorders; Esophageal Neoplasms; Esophagectomy; Esophagoscopy; Fluorouracil; Humans; Irinotecan; Kidney Neoplasms; Lymphatic Metastasis; Male; Neoplasm Staging; Prognosis; Tomography, X-Ray Computed

2003
Prognostic factors in cytokine-refractory renal cell carcinoma treated with irinotecan, Cisplatin, and mitomycin chemotherapy.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Feb-20, Volume: 23, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Renal Cell; Cisplatin; Cytokines; Drug Resistance, Neoplasm; Humans; Irinotecan; Kidney Neoplasms; Mitomycin; Neoplasm Metastasis; Prognosis

2005
Osteosarcoma metastatic to the kidney and iatrogenic hemorrhage.
    Pediatric blood & cancer, 2008, Volume: 50, Issue:3

    Topics: Amputation, Surgical; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Fine-Needle; Bone Neoplasms; Calcinosis; Camptothecin; Child; Combined Modality Therapy; Doxorubicin; Fatal Outcome; Female; Hematuria; Hemorrhage; Humans; Iatrogenic Disease; Ilium; Irinotecan; Kidney Neoplasms; Lung Neoplasms; Methotrexate; Osteosarcoma; Radiography; Tibia; Ultrasonography, Interventional

2008
A case of small cell carcinoma of the kidney.
    Hinyokika kiyo. Acta urologica Japonica, 2007, Volume: 53, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Small Cell; Cisplatin; Drug Administration Schedule; Etoposide; Humans; Irinotecan; Kidney Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Piperidines

2007
Novel SN-38-incorporated polymeric micelle, NK012, strongly suppresses renal cancer progression.
    Cancer research, 2008, Mar-15, Volume: 68, Issue:6

    Topics: Animals; Antineoplastic Agents, Phytogenic; Camptothecin; Carcinoma, Renal Cell; Cell Line, Tumor; Drug Screening Assays, Antitumor; Humans; Irinotecan; Kidney Neoplasms; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Micelles; Prodrugs; Xenograft Model Antitumor Assays

2008
Potent and broad antitumor effects of DX-8951f, a water-soluble camptothecin derivative, against various human tumors xenografted in nude mice.
    Cancer chemotherapy and pharmacology, 1998, Volume: 42, Issue:3

    Topics: Animals; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Camptothecin; Colonic Neoplasms; Humans; Irinotecan; Kidney Neoplasms; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasms; Stomach Neoplasms; Subrenal Capsule Assay; Tumor Cells, Cultured

1998
Antitumor effect of irinotecan hydrochloride (CPT-11) on human renal tumors heterotransplanted in nude mice.
    International journal of urology : official journal of the Japanese Urological Association, 1998, Volume: 5, Issue:4

    Topics: Animals; Antineoplastic Agents, Phytogenic; Camptothecin; Carcinoma, Renal Cell; Humans; Irinotecan; Kidney Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Transplantation, Heterologous; Tumor Cells, Cultured

1998
Cytotoxic pheophorbide-related compounds from Clerodendrum calamitosum and C. cyrtophyllum.
    Journal of natural products, 2001, Volume: 64, Issue:7

    Topics: Adenocarcinoma; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Camptothecin; Cell Survival; Chlorophyll; Dose-Response Relationship, Drug; Drug Resistance; Etoposide; Female; Humans; Ileal Neoplasms; KB Cells; Kidney Neoplasms; Lung Neoplasms; Magnetic Resonance Spectroscopy; Melanoma; Molecular Structure; Ovarian Neoplasms; Plant Leaves; Plant Stems; Plants, Medicinal; Stereoisomerism; Structure-Activity Relationship; Taiwan; Tumor Cells, Cultured; Vincristine

2001